{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:19:37Z","timestamp":1790741977109,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12013-021-00985-y","type":"journal-article","created":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T21:03:05Z","timestamp":1620248585000},"page":"189-200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Prospective Drug Candidates as Human Multidrug Transporter ABCG2 Inhibitors: an In Silico Drug Discovery Study"],"prefix":"10.1007","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4819-2040","authenticated-orcid":false,"given":"Mahmoud A. A.","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esraa A. A.","family":"Badr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa H. M.","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahlah Makki","family":"Almansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Shawky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal A. H.","family":"Mekhemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faris","family":"Alrumaihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud F.","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A. M.","family":"Atia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,5]]},"reference":[{"key":"985_CR1","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","volume":"53","author":"MM Gottesman","year":"2002","unstructured":"Gottesman, M. M. (2002). Mechanisms of cancer drug resistance. Annual Review of Medicine, 53, 615\u201327.","journal-title":"Annual Review of Medicine"},{"key":"985_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrd1984","volume":"5","author":"G Szakacs","year":"2006","unstructured":"Szakacs, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006). Targeting multidrug resistance in cancer. Nature Reviews Drug Discovery, 5, 219\u201334.","journal-title":"Nature Reviews Drug Discovery"},{"key":"985_CR3","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1021\/mp200261n","volume":"8","author":"CP Wu","year":"2011","unstructured":"Wu, C. P., Hsieh, C. H., & Wu, Y. S. (2011). The emergence of drug transporter-mediated multidrug resistance to cancer chemotherapy. Molecular Pharmaceutics, 8, 1996\u20132011.","journal-title":"Molecular Pharmaceutics"},{"key":"985_CR4","first-page":"452","volume":"18","author":"RW Robey","year":"2018","unstructured":"Robey, R. W., Pluchino, K. M., Hall, M. D., Fojo, A. T., Bates, S. E., & Gottesman, M. M. (2018). Revisiting the role of ABC transporters in multidrug-resistant cancer. Nature Reviews: Cancer, 18, 452\u201364.","journal-title":"Nature Reviews: Cancer"},{"key":"985_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0923-2508(01)01194-9","volume":"152","author":"E Dassa","year":"2001","unstructured":"Dassa, E., & Bouige, P. (2001). The ABC of ABCS: a phylogenetic and functional classification of ABC systems in living organisms. Research in Microbiology, 152, 211\u201329.","journal-title":"Research in Microbiology"},{"key":"985_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/1479-7364-3-3-281","volume":"3","author":"V Vasiliou","year":"2009","unstructured":"Vasiliou, V., Vasiliou, K., & Nebert, D. W. (2009). Human ATP-binding cassette (ABC) transporter family. Human Genomics, 3, 281\u201390.","journal-title":"Human Genomics"},{"key":"985_CR7","doi-asserted-by":"publisher","first-page":"5ra11","DOI":"10.1126\/scitranslmed.3000237","volume":"1","author":"H Matsuo","year":"2009","unstructured":"Matsuo, H., Takada, T., Ichida, K., Nakamura, T., Nakayama, A., Ikebuchi, Y., Ito, K., Kusanagi, Y., Chiba, T., Tadokoro, S., Takada, Y., Oikawa, Y., Inoue, H., Suzuki, K., Okada, R., Nishiyama, J., Domoto, H., Watanabe, S., Fujita, M., Morimoto, Y., Naito, M., Nishio, K., Hishida, A., Wakai, K., Asai, Y., Niwa, K., Kamakura, K., Nonoyama, S., Sakurai, Y., Hosoya, T., Kanai, Y., Suzuki, H., Hamajima, N., & Shinomiya, N. (2009). Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Science Translational Medicine, 1, 5ra11.","journal-title":"Science Translational Medicine"},{"key":"985_CR8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.drudis.2007.12.010","volume":"13","author":"G Szakacs","year":"2008","unstructured":"Szakacs, G., Varadi, A., Ozvegy-Laczka, C., & Sarkadi, B. (2008). The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). Drug Discovery Today, 13, 379\u201393.","journal-title":"Drug Discovery Today"},{"key":"985_CR9","doi-asserted-by":"publisher","first-page":"15665","DOI":"10.1073\/pnas.95.26.15665","volume":"95","author":"LA Doyle","year":"1998","unstructured":"Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998). A multidrug resistance transporter from human MCF-7 breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America, 95, 15665\u201370.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"985_CR10","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1242\/jcs.113.11.2011","volume":"113","author":"T Litman","year":"2000","unstructured":"Litman, T., Brangi, M., Hudson, E., Fetsch, P., Abati, A., Ross, D. D., Miyake, K., Resau, J. H., & Bates, S. E. (2000). The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2). Journal of Cell Science, 113, 2011\u201321.","journal-title":"Journal of Cell Science"},{"key":"985_CR11","first-page":"6034","volume":"61","author":"P Perego","year":"2001","unstructured":"Perego, P., De Cesare, M., De Isabella, P., Carenini, N., Beggiolin, G., Pezzoni, G., Palumbo, M., Tartaglia, L., Pratesi, G., Pisano, C., Carminati, P., Scheffer, G. L., & Zunino, F. (2001). A novel 7-modified camptothecin analog overcomes breast cancer resistance protein-associated resistance in a mitoxantrone-selected colon carcinoma cell line. Cancer Research, 61, 6034\u20137.","journal-title":"Cancer Research"},{"key":"985_CR12","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/sj.bjc.6600508","volume":"87","author":"AH van Hattum","year":"2002","unstructured":"van Hattum, A. H., Hoogsteen, I. J., Schluper, H. M., Maliepaard, M., Scheffer, G. L., Scheper, R. J., Kohlhagen, G., Pommier, Y., Pinedo, H. M., & Boven, E. (2002). Induction of breast cancer resistance protein by the camptothecin derivative DX-8951f is associated with minor reduction of antitumour activity. British Journal of Cancer, 87, 665\u201372.","journal-title":"British Journal of Cancer"},{"key":"985_CR13","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/ijc.10100","volume":"97","author":"K Kage","year":"2002","unstructured":"Kage, K., Tsukahara, S., Sugiyama, T., Asada, S., Ishikawa, E., Tsuruo, T., & Sugimoto, Y. (2002). Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization. International Journal of Cancer, 97, 626\u201330.","journal-title":"International Journal of Cancer"},{"key":"985_CR14","doi-asserted-by":"publisher","first-page":"15534","DOI":"10.1038\/s41598-017-15452-z","volume":"7","author":"RJ Ferreira","year":"2017","unstructured":"Ferreira, R. J., Bonito, C. A., Cordeiro, M., Ferreira, M. U. & Dos Santos, D. (2017). Structure-function relationships in ABCG2: insights from molecular dynamics simulations and molecular docking studies. Scientific Reports, 7, 15534\u201350.","journal-title":"Scientific Reports"},{"key":"985_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0005-2736(02)00492-3","volume":"1565","author":"T Litman","year":"2002","unstructured":"Litman, T., Jensen, U., Hansen, A., Covitz, K. M., Zhan, Z. R., Fetsch, P., Abati, A., Hansen, P. R., Horn, T., Skovsgaard, T. & Bates, S. E. (2002). Use of peptide antibodies to probe for the mitoxantrone resistance-associated protein MXR\/BCRP\/ABCP\/ABCG2. Biochimica et Biophysica Acta-Biomembranes, 1565, 6\u201316.","journal-title":"Biochimica et Biophysica Acta-Biomembranes"},{"key":"985_CR16","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1038\/s41467-020-16155-2","volume":"11","author":"BJ Orlando","year":"2020","unstructured":"Orlando, B. J. & & Liao, M. (2020). ABCG2 transports anticancer drugs via a closed-to-open switch. Nature Communications, 11, 2264\u201374.","journal-title":"Nature Communications"},{"key":"985_CR17","doi-asserted-by":"publisher","first-page":"357027","DOI":"10.1155\/2014\/357027","volume":"2014","author":"N Iqbal","year":"2014","unstructured":"Iqbal, N. & Iqbal, N. (2014). Imatinib: a breakthrough of targeted therapy in cancer. Chemotherapy Research and Practice, 2014, 357027\u201336.","journal-title":"Chemotherapy Research and Practice"},{"key":"985_CR18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bbamem.2010.07.031","volume":"1808","author":"L Homolya","year":"2011","unstructured":"Homolya, L., Orban, T. I., Csanady, L. & Sarkadi, B. (2011). Mitoxantrone is expelled by the ABCG2 multidrug transporter directly from the plasma membrane. Biochimica et Biophysica Acta-Biomembranes, 1808, 154\u201363.","journal-title":"Biochimica et Biophysica Acta-Biomembranes"},{"key":"985_CR19","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1182\/blood-2004-04-1398","volume":"104","author":"H Burger","year":"2004","unstructured":"Burger, H., van Tol, H., Boersma, A. W., Brok, M., Wiemer, E. A., Stoter, G., & Nooter, K. (2004). Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)\/ABCG2 drug pump. Blood, 104, 2940\u20132.","journal-title":"Blood"},{"key":"985_CR20","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/clpt.2013.208","volume":"95","author":"LN Eadie","year":"2014","unstructured":"Eadie, L. N., Hughes, T. P., & White, D. L. (2014). Interaction of the efflux transporters ABCB1 and ABCG2 with imatinib, nilotinib, and dasatinib. Clinical Pharmacology and Therapeutics, 95, 294\u2013306.","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"985_CR21","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1158\/0008-5472.CAN-03-3344","volume":"64","author":"PJ Houghton","year":"2004","unstructured":"Houghton, P. J., Germain, G. S., Harwood, F. C., Schuetz, J. D., Stewart, C. F., Buchdunger, E., & Traxler, P. (2004). Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro. Cancer Research, 64, 2333\u20137.","journal-title":"Cancer Research"},{"key":"985_CR22","first-page":"82","volume":"2","author":"P Kannan","year":"2011","unstructured":"Kannan, P., Telu, S., Shukla, S., Ambudkar, S. V., Pike, V. W., Halldin, C., Gottesman, M. M., Innis, R. B., & Hall, M. D. (2011). The \u201cspecific\u201d P-glycoprotein inhibitor tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP\/ABCG2). ACS Chemical. Neuroscience, 2, 82\u20139.","journal-title":"Neuroscience"},{"key":"985_CR23","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1158\/1535-7163.MCT-07-0352","volume":"6","author":"CJ Henrich","year":"2007","unstructured":"Henrich, C. J., Robey, R. W., Bokesch, H. R., Bates, S. E., Shukla, S., Ambudkar, S. V., Dean, M., & McMahon, J. B. (2007). New inhibitors of ABCG2 identified by high-throughput screening. Molecular Cancer Therapeutics, 6, 3271\u20138.","journal-title":"Molecular Cancer Therapeutics"},{"key":"985_CR24","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1080\/14787210.2020.1752665","volume":"18","author":"H Quezada","year":"2020","unstructured":"Quezada, H., Martinez-Vazquez, M., Lopez-Jacome, E., Gonzalez-Pedrajo, B., Andrade, A., Fernandez-Presas, A. M., Tovar-Garcia, A., & Garcia-Contreras, R. (2020). Repurposed anti-cancer drugs: the future for anti-infective therapy? Expert Review of Anti-Infective Therapy, 18, 609\u201312.","journal-title":"Expert Review of Anti-Infective Therapy"},{"key":"985_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41594-018-0049-1","volume":"25","author":"SM Jackson","year":"2018","unstructured":"Jackson, S. M., Manolaridis, I., Kowal, J., Zechner, M., Taylor, N. M. I., Bause, M., Bauer, S., Bartholomaeus, R., Bernhardt, G., Koenig, B., Buschauer, A., Stahlberg, H., Altmann, K. H., & Locher, K. P. (2018). Structural basis of small-molecule inhibition of human multidrug transporter ABCG2. Nature Structural & Molecular Biology, 25, 333\u201340.","journal-title":"Nature Structural & Molecular Biology"},{"key":"985_CR26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev.biophys.29.1.291","volume":"29","author":"MA Marti-Renom","year":"2000","unstructured":"Marti-Renom, M. A., Stuart, A. C., Fiser, A., Sanchez, R., Melo, F., & Sali, A. (2000). Comparative protein structure modeling of genes and genomes. Annual Review of Biophysics and Biomolecular Structure, 29, 291\u2013325.","journal-title":"Annual Review of Biophysics and Biomolecular Structure"},{"key":"985_CR27","doi-asserted-by":"publisher","first-page":"W368","DOI":"10.1093\/nar\/gki464","volume":"33","author":"JC Gordon","year":"2005","unstructured":"Gordon, J. C., Myers, J. B., Folta, T., Shoja, V., Heath, L. S., & Onufriev, A. (2005). H++: a server for estimating pKas and adding missing hydrogens to macromolecules. Nucleic Acids Research, 33, W368\u201371.","journal-title":"Nucleic Acids Research"},{"key":"985_CR28","doi-asserted-by":"publisher","first-page":"D668","DOI":"10.1093\/nar\/gkj067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"Wishart, D. S., Knox, C., Guo, A. C., Shrivastava, S., Hassanali, M., Stothard, P., Chang, Z., & Woolsey, J. (2006). DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Research, 34, D668\u201372.","journal-title":"Nucleic Acids Research"},{"key":"985_CR29","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., Assempour, N., Iynkkaran, I., Liu, Y., Maciejewski, A., Gale, N., Wilson, A., Chin, L., Cummings, R., Le, D., Pon, A., Knox, C., & Wilson, M. (2018). DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Research, 46, D1074\u2013D82.","journal-title":"Nucleic Acids Research"},{"key":"985_CR30","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1021\/ci100031x","volume":"50","author":"PC Hawkins","year":"2010","unstructured":"Hawkins, P. C., Skillman, A. G., Warren, G. L., Ellingson, B. A., & Stahl, M. T. (2010). Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database. Journal of Chemical Information and Modeling, 50, 572\u201384.","journal-title":"Journal of Chemical Information and Modeling"},{"key":"985_CR31","unstructured":"OMEGA 2.5.1.4. Santa Fe, NM, USA. OpenEye Scientific Software, 2013."},{"key":"985_CR32","unstructured":"SZYBKI 1.9.0.3. Santa Fe, NM, USA. OpenEye Scientific Software, 2016."},{"key":"985_CR33","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1016\/0040-4020(80)80168-2","volume":"36","author":"J Gasteiger","year":"1980","unstructured":"Gasteiger, J., & Marsili, M. (1980). Iterative partial equalization of orbital electronegativity\u2014a rapid access to atomic charges. Tetrahedron, 36, 3219\u201328.","journal-title":"Tetrahedron"},{"key":"985_CR34","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30, 2785\u201391.","journal-title":"Journal of Computational Chemistry"},{"key":"985_CR35","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/nprot.2016.051","volume":"11","author":"S Forli","year":"2016","unstructured":"Forli, S., Huey, R., Pique, M. E., Sanner, M. F., Goodsell, D. S., & Olson, A. J. (2016). Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nature Protocols, 11, 905\u201319.","journal-title":"Nature Protocols"},{"key":"985_CR36","volume-title":"AMBER","author":"DA Case","year":"2016","unstructured":"Case, D. A., Betz, R. M., Cerutti, D. S., Cheatham, T. E., Darden, T. A., Duke, R. E., Giese, T. J., Gohlke, H., Goetz, A. W., Homeyer, N., Izadi, S., Janowski, P., Kaus, J., Kovalenko, A., Lee, T. S., LeGrand, S., Li, P., Lin, C., Luchko, T., Luo, R., Madej, B., Mermelstein, D., Merz, K. M., Monard, G., Nguyen, H., Nguyen, H. T., Omelyan, I., Onufriev, A., Roe, D. R., Roitberg, A., Sagui, C., Simmerling, C. L., Botello-Smith, W. M., Swails, J., Walker, R. C., Wang, J., Wolf, R. M., Wu, X., Xiao, L., & Kollman, P. A. (2016). AMBER16. San Francisco, USA: University of California."},{"key":"985_CR37","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry, 25, 1157\u201374.","journal-title":"Journal of Computational Chemistry"},{"key":"985_CR38","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier, J. A., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K. E., & Simmerling, C. (2015). ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. Journal of Chemical Theory and Computation, 11, 3696\u2013713.","journal-title":"Journal of Chemical Theory and Computation"},{"key":"985_CR39","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/jcc.10128","volume":"23","author":"A Jakalian","year":"2002","unstructured":"Jakalian, A., Jack, D. B., & Bayly, C. I. (2002). Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation. Journal of Computational Chemistry, 23, 1623\u201341.","journal-title":"Journal of Computational Chemistry"},{"key":"985_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0301-4622(98)00226-9","volume":"78","author":"B Roux","year":"1999","unstructured":"Roux, B., & Simonson, T. (1999). Implicit solvent models. Biophysical Chemistry, 78, 1\u201320.","journal-title":"Biophysical Chemistry"},{"key":"985_CR41","doi-asserted-by":"publisher","first-page":"10269","DOI":"10.1021\/j100142a004","volume":"97","author":"CI Bayly","year":"1993","unstructured":"Bayly, C. I., Cieplak, P., Cornell, W. D., & Kollman, P. A. (1993). A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges - the RESP model. Journal of Physical Chemistry, 97, 10269\u201380.","journal-title":"Journal of Physical Chemistry"},{"key":"985_CR42","volume-title":"Gaussian 09","author":"MJ Frisch","year":"2009","unstructured":"Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., Scalmani, G., Barone, V., Mennucci, B., Petersson, G. A., Nakatsuji, H., Caricato, M., Li, X., Hratchian, H. P., Izmaylov, A. F., Bloino, J., Zheng, G., Sonnenberg, J. L., Hada, M., Ehara, M., Toyota, K., Fukuda, R., Hasegawa, J., Ishida, M., Nakajima, T., Honda, Y., Kitao, O., Nakai, H., Vreven, T., Montgomery, J. A., Peralta, J. E., Ogliaro, F., Bearpark, M., Heyd, J. J., Brothers, E., Kudin, K. N., Staroverov, V. N., Kobayashi, R., Normand, J., Raghavachari, K., Rendell, A., Burant, J. C., Iyengar, S. S., Tomasi, J., Cossi, M., Rega, N., Millam, J. M., Klene, M., Knox, J. E., Cross, J. B., Bakken, V., Adamo, C., Jaramillo, J., Gomperts, R., Stratmann, R. E., Yazyev, O., Austin, A. J., Cammi, R., Pomelli, C., Ochterski, J. W., Martin, R. L., Morokuma, K., Zakrzewski, V. G., Voth, G. A., Salvador, P., Dannenberg, J. J., Dapprich, S., Daniels, A. D., Farkas, \u00d6., Foresman, J. B., Ortiz, J. V., Cioslowski, J., & Fox, D. J. (2009). Gaussian 09. Wallingford CT, USA.: Gaussian Inc."},{"key":"985_CR43","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: AnN\u00b7log(N) method for Ewald sums in large systems. Journal of Chemical Physics, 98, 10089\u201392.","journal-title":"Journal of Chemical Physics"},{"key":"985_CR44","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1063\/1.448118","volume":"81","author":"HJC Berendsen","year":"1984","unstructured":"Berendsen, H. J. C., Postma, J. P. M., Vangunsteren, W. F., Dinola, A., & Haak, J. R. (1984). Molecular-dynamics with coupling to an external bath. Journal of Chemical Physics, 81, 3684\u201390.","journal-title":"Journal of Chemical Physics"},{"key":"985_CR45","volume-title":"BIOVIA Discovery Studio Visualize 2019, version 2019","author":"Dassault Syst\u00e8mes BIOVIA.","year":"2019","unstructured":"Dassault Syst\u00e8mes BIOVIA. (2019). BIOVIA Discovery Studio Visualize 2019, version 2019. San Diego, CA, USA: Dassault Syst\u00e8mes BIOVIA."},{"key":"985_CR46","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1023\/A:1008763014207","volume":"18","author":"I Massova","year":"2000","unstructured":"Massova, I., & Kollman, P. A. (2000). Combined molecular mechanical and continuum solvent approach (MM-PBSA\/GBSA) to predict ligand binding. Perspectives in Drug Discovery and Design, 18, 113\u201335.","journal-title":"Perspectives in Drug Discovery and Design"},{"key":"985_CR47","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/prot.20033","volume":"55","author":"A Onufriev","year":"2004","unstructured":"Onufriev, A., Bashford, D., & Case, D. A. (2004). Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins, 55, 383\u201394.","journal-title":"Proteins"},{"key":"985_CR48","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/jmv.25726","volume":"92","author":"Z Liu","year":"2020","unstructured":"Liu, Z., Xiao, X., Wei, X., Li, J., Yang, J., Tan, H., Zhu, J., Zhang, Q., Wu, J., & Liu, L. (2020). Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. Journal of Medical Virology, 92, 595\u2013601.","journal-title":"Journal of Medical Virology"},{"key":"985_CR49","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fphar.2019.00208","volume":"10","author":"Y Toyoda","year":"2019","unstructured":"Toyoda, Y., Takada, T. & Suzuki, H. (2019). Inhibitors of human ABCG2: from technical background to recent updates with clinical implications. Frontiers in Pharmacology, 10, 208\u201316.","journal-title":"Frontiers in Pharmacology"},{"key":"985_CR50","doi-asserted-by":"publisher","first-page":"4035","DOI":"10.1021\/acs.jmedchem.5b01684","volume":"59","author":"M De Vivo","year":"2016","unstructured":"De Vivo, M., Masetti, M., Bottegoni, G., & Cavalli, A. (2016). Role of molecular dynamics and related methods in drug discovery. Journal of Medicinal Chemistry, 59, 4035\u201361.","journal-title":"Journal of Medicinal Chemistry"},{"key":"985_CR51","doi-asserted-by":"crossref","unstructured":"Kerrigan, J. E. (2013) Molecular dynamics simulations in drug design. In S. Kortagere (ed.), In Silico Models for Drug Discovery. (pp. 95\u2013113). Totowa, NJ: Humana Press.","DOI":"10.1007\/978-1-62703-342-8_7"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-021-00985-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-021-00985-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-021-00985-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T15:54:14Z","timestamp":1675266854000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-021-00985-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,5]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["985"],"URL":"https:\/\/doi.org\/10.1007\/s12013-021-00985-y","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,5]]},"assertion":[{"value":"8 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}